Cranberry proanthocyanidins inhibit the adherence properties of Candida albicans and cytokine secretion by oral epithelial cells

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Feldman, Mark ^a   Tanabe, Shinichi ^a   Howell, Amy ^b   Grenier, Daniel ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID RESIN; CRYSTAL VIOLET; INTERLEUKIN 6; INTERLEUKIN 8; PHOSPHOTRANSFERASE; PROANTHOCYANIDIN; TRANSCRIPTION FACTOR RELA; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN DERIVATIVE; PLANT EXTRACT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL ADHESION; CONTROLLED STUDY; CRANBERRY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DILUTION; ENZYME PHOSPHORYLATION; FLUOROMETRY; FUNGUS GROWTH; HUMAN; HUMAN CELL; IMMUNOASSAY; MOUTH MUCOSA; MUCOSA INFLAMMATION; NONHUMAN; PHOSPHORYLATION; SALIVA; THRUSH; CHEMISTRY; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYTOTHERAPY; SECRETION;

ANTI-INFLAMMATORY AGENTS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CELL ADHESION; EPITHELIAL CELLS; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; MOUTH MUCOSA; NF-KAPPA B; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PHYTOTHERAPY; PLANT EXTRACTS; PROANTHOCYANIDINS; SALIVA; VACCINIUM MACROCARPON;

EID: 84855819034     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-6     Document Type: Article

References (58)

1. Zunt SL. Oral candidiasis: Diagnosis and treatment. J Pract Hyg 2000, 9:31-36.
2. Ramage G, Tomsett K, Wickes BL, Lopez-Ribot JL, Redding SW. Denture stomatitis: a role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 98(1):53-59. 10.1016/j.tripleo.2003.04.002, 15243471.
3. Wachtler B, Wilson D, Haedicke K, Dalle F, Hube B. From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS One 2011, 6(2):e17046. 10.1371/journal.pone.0017046, 3044159, 21407800.
4. Li L, Finnegan MB, Ozkan S, Kim Y, Lillehoj PB, Ho CM, Lux R, Mito R, Loewy Z, Shi W. In vitro study of biofilm formation and effectiveness of antimicrobial treatment on various dental material surfaces. Mol Oral Microbiol 2010, 25(6):384-390. 10.1111/j.2041-1014.2010.00586.x, 21040512.
5. Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 2006, 5(10):1604-1610. 10.1128/EC.00194-06, 1595337, 17030992.
6. Umeyama T, Kaneko A, Nagai Y, Hanaoka N, Tanabe K, Takano Y, Niimi M, Uehara Y. Candida albicans protein kinase CaHsl1p regulates cell elongation and virulence. Mol Microbiol 2005, 55(2):381-395.
7. Claveau I, Mostefaoui Y, Rouabhia M. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans. Matrix Biol 2004, 23(7):477-486. 10.1016/j.matbio.2004.08.006, 15579314.
8. Dong X, Shi W, Zeng Q, Xie L. Roles of adherence and matrix metalloproteinases in growth patterns of fungal pathogens in cornea. Curr Eye Res 2005, 30(8):613-620. 10.1080/02713680590968196, 16109640.
9. Parnanen P, Meurman JH, Sorsa T. The effects of Candida proteinases on human proMMP-9, TIMP-1 and TIMP-2. Mycoses 2011, 54(4):325-330. 10.1111/j.1439-0507.2010.01889.x, 20406392.
10. Yuan X, Mitchell BM, Wilhelmus KR. Expression of matrix metalloproteinases during experimental Candida albicans keratitis. Invest ophthalmol Vis Science 2009, 50(2):737-742.
11. Jiang Y, Russell TR, Graves DT, Cheng H, Nong SH, Levitz SM. Monocyte chemoattractant protein 1 and interleukin-8 production in mononuclear cells stimulated by oral microorganisms. Infect Immun 1996, 64(11):4450-4455. 174397, 8890191.
12. Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000, 11(2):172-198. 10.1177/10454411000110020301, 12002814.
13. Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Hoyer LL, Douglas LJ, Ghannoum MA. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 2001, 80(3):903-908. 10.1177/00220345010800031101, 11379893.
14. Dorocka-Bobkowska B, Duzgunes N, Konopka K. AmBisome and Amphotericin B inhibit the initial adherence of Candida albicans to human epithelial cell lines, but do not cause yeast detachment. Med Sci Monit 2009, 15(9):BR262-269.
15. Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. Jama 1994, 271(10):751-754. 10.1001/jama.1994.03510340041031, 8093138.
16. Neto CC. Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases. Mol Nutr Food Res 2007, 51(6):652-664. 10.1002/mnfr.200600279, 17533651.
17. Yan X, Murphy BT, Hammond GB, Vinson JA, Neto CC. Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem 2002, 50(21):5844-5849. 10.1021/jf0202234, 12358448.
18. Foo LY, Lu Y, Howell AB, Vorsa N. The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phytochemistry 2000, 54(2):173-181. 10.1016/S0031-9422(99)00573-7, 10872208.
19. La VD, Howell AB, Grenier D. Cranberry proanthocyanidins inhibit MMP production and activity. J Dent Res 2009, 88(7):627-632. 10.1177/0022034509339487, 19641150.
20. Foo LY, Lu Y, Howell AB, Vorsa N. A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod 2000, 63(9):1225-1228. 10.1021/np000128u, 11000024.
21. Messier C, Grenier D. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. Mycoses 2011, 54(6):e801-6. 10.1111/j.1439-0507.2011.02028.x, 21615543.
22. Gilchrist EP, Moyer MP, Shillitoe EJ, Clare N, Murrah VA. Establishment of a human polyclonal oral epithelial cell line. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000, 90(3):340-347. 10.1067/moe.2000.107360, 10982956.
23. Avon SL, Goulet JP, Deslauriers N. Removable acrylic resin disk as a sampling system for the study of denture biofilms in vivo. J Prosthet Dent 2007, 97(1):32-38. 10.1016/j.prosdent.2006.12.001, 17280889.
24. Ishida K, de Mello JC, Cortez DA, Filho BP, Ueda-Nakamura T, Nakamura CV. Influence of tannins from Stryphnodendron adstringens on growth and virulence factors of Candida albicans. J Antimicrob Chemother 2006, 58(5):942-949. 10.1093/jac/dkl377, 16973655.
25. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998, 11:382-402. 106838, 9564569.
26. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis 2001, 7(2):277-281. 10.3201/eid0702.010226, 2631701, 11294723.
27. Li F, Palecek SP. Distinct domains of the Candida albicans adhesin Eap1p mediate cell-cell and cell-substrate interactions. Microbiology 2008, 154(Pt 4):1193-1203.
28. Martinez LR, Mihu MR, Tar M, Cordero RJ, Han G, Friedman AJ, Friedman JM, Nosanchuk JD. Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model. J Infect Dis 2010, 201(9):1436-1440. 10.1086/651558, 20331379.
29. Privett BJ, Nutz ST, Schoenfisch MH. Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation. Biofouling 2010, 26(8):973-983. 10.1080/08927014.2010.534552, 21082455.
30. Eydelnant IA, Tufenkji N. Cranberry derived proanthocyanidins reduce bacterial adhesion to selected biomaterials. Langmuir 2008, 24(18):10273-10281. 10.1021/la801525d, 18698853.
31. Howell AB, Botto H, Combescure C, Blanc-Potard AB, Gausa L, Matsumoto T, Tenke P, Sotto A, Lavigne JP. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis 2010, 10:94. 10.1186/1471-2334-10-94, 2873556, 20398248.
32. Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, Leahy M. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry 2005, 66(18):2281-2291. 10.1016/j.phytochem.2005.05.022, 16055161.
33. Koo H, Duarte S, Murata RM, Scott-Anne K, Gregoire S, Watson GE, Singh AP, Vorsa N. Influence of cranberry proanthocyanidins on formation of biofilms by Streptococcus mutans on saliva-coated apatitic surface and on dental caries development in vivo. Caries Res 2010, 44(2):116-126. 10.1159/000296306, 2883842, 20234135.
34. La VD, Howell AB, Grenier D. Anti-Porphyromonas gingivalis and anti-inflammatory activities of A-type cranberry proanthocyanidins. Antimicrob Agents Chemother 54(5):1778-1784.
35. Duarte S, Gregoire S, Singh AP, Vorsa N, Schaich K, Bowen WH, Koo H. Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms. FEMS Microbiol Lett 2006, 257(1):50-56. 10.1111/j.1574-6968.2006.00147.x, 16553831.
36. Sharon N. Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta 2006, 1760(4):527-537. 10.1016/j.bbagen.2005.12.008, 16564136.
37. Sundstrom P. Adhesion in Candida spp. Cell Microbiol 2002, 4(8):461-469. 10.1046/j.1462-5822.2002.00206.x, 12174081.
38. Tronchin G, Pihet M, Lopes-Bezerra LM, Bouchara JP. Adherence mechanisms in human pathogenic fungi. Med Mycol 2008, 46(8):749-772. 10.1080/13693780802206435, 18651303.
39. Budtz-Jorgensen E. Candida-associated denture stomatitis and angular cheilitis. Oral candidosis 1990, 156-183. London: Wright-Butterworth and Co. Ltd, Macfarlane LP, Samaranayake TW.
40. Radford DR, Sweet SP, Challacombe SJ, Walter JD. Adherence of Candida albicans to denture-base materials with different surface finishes. J Dent 1998, 26(7):577-583. 10.1016/S0300-5712(97)00034-1, 9754746.
41. de Souza RD, Mores AU, Cavalca L, Rosa RT, Samaranayake LP, Rosa EA. Cell surface hydrophobicity of Candida albicans isolated from elder patients undergoing denture-related candidosis. Gerodontology 2009, 26(2):157-161. 10.1111/j.1741-2358.2008.00229.x, 19490138.
42. Bodet C, Grenier D, Chandad F, Ofek I, Steinberg D, Weiss EI. Potential oral health benefits of cranberry. Crit Rev Food Sci Nutr 2008, 48(7):672-680. 10.1080/10408390701636211, 18663617.
43. Yamanaka A, Kimizuka R, Kato T, Okuda K. Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation. Oral Microbiol Immunol 2004, 19(3):150-154. 10.1111/j.0902-0055.2004.00130.x, 15107065.
44. Pinzon-Arango PA, Liu Y, Camesano TA. Role of cranberry on bacterial adhesion forces and implications for Escherichia coli-uroepithelial cell attachment. J Med Food 2009, 12(2):259-270. 10.1089/jmf.2008.0196, 19257836.
45. Liu Y, Black MA, Caron L, Camesano TA. Role of cranberry juice on molecular-scale surface characteristics and adhesion behavior of Escherichia coli. Biotechnol Bioeng 2006, 93(2):297-305. 10.1002/bit.20675, 16142789.
46. Zhu W, Filler SG. Interactions of Candida albicans with epithelial cells. Cell Microbiol 2010, 12(3):273-282. 10.1111/j.1462-5822.2009.01412.x, 19919567.
47. Richardson M, Rautemaa R. How the host fights against Candida infections. Front Biosci (Schol Ed) 2009, 1:246-257.
48. Dongari-Bagtzoglou A, Fidel PL. The host cytokine responses and protective immunity in oropharyngeal candidiasis. J Dent Res 2005, 84(11):966-977. 10.1177/154405910508401101, 16246925.
49. Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005, 175(6):3463-3468.
50. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242. 10.1146/annurev.immunol.18.1.217, 10837058.
51. Bodet C, Chandad F, Grenier D. Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res 2006, 85(3):235-239. 10.1177/154405910608500306, 16498070.
52. Bodet C, Chandad F, Grenier D. Cranberry components inhibit interleukin-6, interleukin-8, and prostaglandin E production by lipopolysaccharide-activated gingival fibroblasts. Eur J Oral Sci 2007, 115(1):64-70. 10.1111/j.1600-0722.2007.00415.x, 17305718.
53. Huang Y, Nikolic D, Pendland S, Doyle BJ, Locklear TD, Mahady GB. Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-kappabeta transcriptional response in vitro. Pharm Biol 2009, 47(1):18-25. 10.1080/13880200802397996, 2849675, 20376297.
54. Li M, Chen Q, Shen Y, Liu W. Candida albicans phospholipomannan triggers inflammatory responses of human keratinocytes through Toll-like receptor 2. Exp Dermatol 2009, 18(7):603-610. 10.1111/j.1600-0625.2008.00832.x, 19196344.
55. Pietrella D, Rachini A, Pandey N, Schild L, Netea M, Bistoni F, Hube B, Vecchiarelli A. The inflammatory response induced by aspartic proteases of Candida albicans is independent of proteolytic activity. Infect Immun 2010, 78(11):4754-4762. 10.1128/IAI.00789-10, 2976325, 20713630.
56. Lee HS, Lee CS, Yang CJ, Su SL, Salter DM. Candida albicans induces cyclo-oxygenase 2 expression and prostaglandin E2 production in synovial fibroblasts through an extracellular-regulated kinase 1/2 dependent pathway. Arthritis Res Ther 2009, 11(2):R48. 10.1186/ar2661, 2688198, 19327173.
57. Parti RP, Loper R, Brown GD, Gordon S, Taylor PR, Bonventre JV, Murphy RC, Williams DL, Leslie CC. Cytosolic phospholipase a2 activation by Candida albicans in alveolar macrophages: role of dectin-1. Am J Respir Cell Mol Biol 2010, 42(4):415-423. 10.1165/rcmb.2009-0110OC, 2848735, 19502385.
58. Deziel BA, Patel K, Neto C, Gottschall-Pass K, Hurta RA. Proanthocyanidins from the American Cranberry (Vaccinium macrocarpon) inhibit matrix metalloproteinase-2 and matrix metalloproteinase-9 activity in human prostate cancer cells via alterations in multiple cellular signalling pathways. J Cell Biochem 2010, 111(3):742-754. 10.1002/jcb.22761, 20626034.